APPLICATION SITE CELLULITIS

This adverse event was reported 67 times

These drugs are most commonly taken by patients reporting APPLICATION SITE CELLULITIS:

# Drug Count
0 MECHLORETHAMINE HYDROCHLORIDE 5
1 METHOTREXATE 5
2 METHOTREXATE SODIUM 5
3 ALLOPURINOL 4
4 ETANERCEPT 4
5 FUROSEMIDE 4
6 TAPINAROF 4
7 BUPRENORPHINE 3
8 COLLAGENASE SANTYL 3
9 NIFEDIPINE 3
See all common drugs associated with APPLICATION SITE CELLULITIS

APPLICATION SITE CELLULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LULICONAZOLE 1 0.0057
1 MECHLORETHAMINE HYDROCHLORIDE 5 0.0022
2 TAPINAROF 4 0.0020
3 COLLAGENASE SANTYL 3 0.0018
4 BEXAROTENE 1 0.0008
5 EFINACONAZOLE 1 0.0005
6 DICLOFENAC EPOLAMINE 2 0.0005
7 CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 1 0.0003
8 CLINDAMYCIN PHOSPHATE TOPICAL 1 0.0003
9 CLINDAMYCIN PHOSPHATE 1 0.0002
See all drugs enriched for association with APPLICATION SITE CELLULITIS

APPLICATION SITE CELLULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aryl Hydrocarbon Receptor Agonist [EPC] 4 0.0020
1 Chloride Channel Activator [EPC] 1 0.0001
2 Barbiturate [EPC] 1 0.0001
3 RNA Synthetase Inhibitor Antibacterial [EPC] 1 0.0001
4 Folate Analog [EPC] 2 0.0000
5 Vitamin A [EPC] 2 0.0000
6 PCSK9 Inhibitor [EPC] 1 0.0000
7 Nicotinic Acid [EPC] 2 0.0000
8 Partial Opioid Agonist [EPC] 3 0.0000
9 Antidote [EPC] 2 0.0000
See all drug classes enriched for association with APPLICATION SITE CELLULITIS